Found 662 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer PHASE3 This is a randomized, prospective, multicenter, open-label, Phase III clini...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Learn More & Join Trial
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy PHASE2 Radiotherapy can activate local and systemic immune responses through a var...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE2 Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) PHASE2 This study is a prospective cohort clinical trial that aims to investigate ...
Show More Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Learn More & Join Trial
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy PHASE2 Head and neck cancer is the malignant tumor with the highest morbidity and ...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial